Silverarc Capital Management, LLC Ngm Biopharmaceuticals Inc Transaction History

Silverarc Capital Management, LLC

  • $353 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 28, 2022
BUY
$12.59 - $17.67 $78,234 - $109,801
6,214 Added 7.04%
94,517 $1.24 Million
Q2 2022

Jul 25, 2022
SELL
$10.58 - $17.5 $1.19 Million - $1.96 Million
-112,191 Reduced 55.96%
88,303 $1.13 Million
Q1 2022

May 13, 2022
BUY
$13.81 - $18.6 $2.77 Million - $3.73 Million
200,494 New
200,494 $3.06 Million

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email